NDC 0409-7447 - Cimetidine in Sodium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7447
- Package NDCs from labels
- 0409-7447-16
- Manufacturer
- HOSPIRA, INC.
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CIMETIDINE in 0.9% Sodium Chloride Injection, USP | HOSPIRA, INC. | 2006-04-13 | Human prescription drug label |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Cimetidine | ACTIVE INGREDIENT | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Cimetidine | ACTIVE MOIETY | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | e5ee8caa-b6ca-45ba-98fb-8305e6282141 | 2024-04-10 | Adverse reactions | Sodium Chloride |
| Bortezomib | BORTEZOMIB | Hospira, Inc. | 41e3de39-8278-4a75-badf-601e4602080d | 2024-04-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Cimetidine | CIMETIDINE | Proficient Rx LP | 5c2e1f52-4021-4f70-9b2b-63af17094187 | 2024-04-01 | Adverse reactions | Cimetidine |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Spectra Medical Deviecs, LLC | 7e316d21-d6ad-4976-bd90-268fd7e51361 | 2024-01-12 | Adverse reactions | Sodium Chloride |
| Diazepam | DIAZEPAM | Hospira, Inc. | 41044928-dd1f-40bf-1fa6-709dff559124 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 037ac04d-f8f3-4bb8-993a-ac8f7683ff83 | 2024-01-04 | Warnings, Adverse reactions | Sodium chloride |
| Atracurium Besylate | ATRACURIUM BESYLATE | Hospira, Inc. | de1c2dcd-295b-47ce-b7a1-a8be59939a54 | 2023-11-23 | Warnings, Adverse reactions | Hospira, Inc. |
| rocuronium bromide | ROCURONIUM BROMIDE | Hospira, Inc. | f01f9986-43f9-40e8-9506-11bfe78f9242 | 2023-08-29 | Warnings, Adverse reactions | Hospira, Inc. |
| CIMETIDINE | CIMETIDINE | Chartwell RX, LLC | 01997826-7ca1-473e-bfc9-075b14b58a35 | 2023-08-18 | Adverse reactions | CIMETIDINE |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | b6e33138-841a-471f-a934-c4086cbc23f6 | 2023-07-17 | Warnings, Adverse reactions | Sodium Chloride |
| rocuronium bromide | ROCURONIUM BROMIDE | Hospira, Inc. | c96726ef-f1fa-4ebb-ba33-3479c3902a8e | 2023-06-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | b598c237-032d-4bb5-0e92-50eabd863dac | 2023-06-04 | Warnings, Adverse reactions | Hospira, Inc. |
| BORTEZOMIB | BORTEZOMIB | Hospira, Inc. | 9fdf6169-699f-40eb-bda1-760253062b3c | 2023-02-27 | Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Liebel-Flarsheim Company LLC | e4540d03-06b4-4b4d-b859-75c13e5c20dd | 2022-12-20 | Warnings, Adverse reactions | SODIUM CHLORIDE |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2fae04e3-20b1-4b8c-b1fb-646b384836f1 | 2022-12-07 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 51da05ce-e3c4-4ef5-a845-dc869152e17f | 2022-10-24 | Warnings, Adverse reactions | Sodium Chloride |
| Bleomycin | BLEOMYCIN | Hospira, Inc. | 905e0984-2ce3-481c-b1a0-0ef0a616479a | 2022-08-25 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Bleomycin | BLEOMYCIN | Hospira, Inc. | e629ba5a-4e08-4249-9551-af6dbd98a7e4 | 2022-08-25 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 123bd10a-90c7-499e-97f6-acf7e0f0fb4e | 2022-07-29 | Warnings, Adverse reactions | SODIUM CHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.